Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
, Aug. 12, 2013
/PRNewswire/ -- The EMMES Corporation today announced that Dr. Anne Lindblad
, executive vice president, has been promoted to president and chief executive officer. Lindblad replaces Dr. Donald (Don) Stablein
, who has been named past president.
(Photo: http://photos.prnewswire.com/prnh/20130812/PH57809 )
"My first goal is to continue the legacy that Don and I built at EMMES," said Lindblad. "That means maintaining our top-quality workforce and providing high-level, valued support to government, industry, foundation and university clients. In addition to our core clinical trials and research support, we have the opportunity to expand on our genomic and bioinformatics expertise and platforms. I am especially interested in exploring ways EMMES can provide services to a wider range of research institutions and biotech companies based here in Maryland."
Stablein, who joined the company in 1980, served as its president/CEO since 1992. In his new role as past president, he will continue to provide project support and will be an ambassador for EMMES.
"Anne and I have been partners for more than 30 years," said Stablein, "and I'm leaving the company in excellent hands. We have an outstanding leadership team, a talented and energetic employee base, and a 35-year history with long-term client relationships. I'm looking forward to the next chapter in EMMES' evolution."
A biostatistician with experience in clinical design and project management, Lindblad joined EMMES in 1982 and became vice president in 1992 and executive vice president in 2006. During her 30-year career at EMMES, she has led major projects in ophthalmology, oncology, nephrology, transplantation, neurology, stroke, traumatic brain injury, dental disease and swallowing disorders. She has served as a reviewer of grant and contract applications for the National Institutes of Health and has chaired or served on Data and Safety Monitoring Committees in multiple disease areas. In addition, she has served on the board of directors and as president of the Society for Clinical Trials, as well as the clinical trials section editor for JAMA Ophthalmology, formerly the Archives of Ophthalmology.
Lindblad has authored or co-authored more than 100 publications and presentations.
She holds a Ph.D. in statistics from the George Washington University, a master's degree in biostatistics from the Medical College of Virginia, and a bachelor's degree in Statistics from Hollins College. Lindblad lives in Middleburg, Virginia, with her husband and two daughters.
About The EMMES Corporation
EMMES is a professional partner to clinicians, scientists, and program leaders around the world. Founded in 1977, the company provides scientific and technical support for clinical research studies funded by industry, foundations and government agencies. EMMES has more than 350 employees whose specialties range from biomedical research to biostatistics to information technology. Its staff is committed to the highest quality of research, evidenced by numerous major scientific publications and presentations. In addition to its headquarters in Rockville, MD, the company has offices in Canada and India. For more information, visit www.emmes.com.
SOURCE The EMMES Corporation